Webinar
P.A.C.E. CE: The Fentanyl Crisis and the Impact of Clinical Testing
May 3, 2024
Live event: May 21, 2024 at 1 p.m. ET
Duration: 30 minutes
During this presentation, Dr. Jaeger will dive into the current fentanyl crisis in the U.S. and the important role the laboratory plays in clinical screening to improve patient outcomes. Illicit fentanyl has led to an alarming rate of overdoses and increasing challenges to healthcare providers as they attempt to manage patients in emergency and non-acute settings.
At the conclusion of the webinar, attendees will be able to:
- Determine the differences between pharmaceutical and illicit fentanyl use.
- Understand how deaths involving illicitly manufactured fentanyl are on the rise.
- Explain why standard opiate testing approaches do not detect synthetic opioids like fentanyl.
- Discover which states have responded to the fentanyl crisis by mandating fentanyl testing.
Disclosures: This promotional educational activity is brought to you by QuidelOrtho. The speakers are presenting on behalf of QuidelOrtho and must present information in accordance with applicable and/or local regulatory country requirements. QuidelOrtho is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.
About Our Speakers:
About Our Speakers:
Dr. Jared Jaeger
Clinical Science Liaison at QuidelOrtho
Dr. Jared Jaeger studied biology and chemistry at Drury University before he earned his Ph.D. in physical chemistry in 2006 at the University of Georgia. He worked for Quest Diagnostics from 2007-2016 in several roles including Genomic & Esoteric Testing Specialist, Prescription Drug Monitoring Specialist and Health Plans Director. He joined QuidelOrtho in 2016 and is a North American Clinical Science Liaison. His responsibilities include commercial support for QuidelOrtho’s Immunoassay product line with a focus in cardiology, infectious disease, and metabolism.
Dr. Jared Jaeger studied biology and chemistry at Drury University before he earned his Ph.D. in physical chemistry in 2006 at the University of Georgia. He worked for Quest Diagnostics from 2007-2016 in several roles including Genomic & Esoteric Testing Specialist, Prescription Drug Monitoring Specialist and Health Plans Director. He joined QuidelOrtho in 2016 and is a North American Clinical Science Liaison. His responsibilities include commercial support for QuidelOrtho’s Immunoassay product line with a focus in cardiology, infectious disease, and metabolism.
